[ASND] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
11-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -18.33%
YoY- -99.86%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 22,896 15,290 6,160 6,828 4,897 1,113 1,022 690.21%
PBT -202,069 -169,122 -81,366 -125,257 -106,176 -80,343 -134,442 31.11%
Tax 5,349 -167 -47 241 -114 5 -68 -
NP -207,418 -168,955 -81,319 -125,498 -106,062 -80,348 -134,374 33.45%
Tax Rate - - - - - - - -
Total Cost 230,314 184,245 87,479 132,326 110,959 81,461 135,396 42.36%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -905.91 -1,105.00 -1,320.11 -1,837.99 -2,165.86 -7,219.05 -13,148.14 -83.11%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -3.70 -3.03 -1.46 -2.21 -1.97 -1.47 -2.50 29.77%
EPS Diluted -3.70 -3.03 -1.46 -2.21 -1.97 -1.47 -2.50 29.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.